Liu Wenhui,Zheng Xiaolian,Hu Cairong,Ji Hongbing,Pan Jianji,Chen Juhui.Research progress in the preoperative radiotherapy and immunotherapy for primary liver cancer[J].Chinese Journal of Radiological Medicine and Protection,2022,42(3):235-240 |
Research progress in the preoperative radiotherapy and immunotherapy for primary liver cancer |
Received:November 02, 2021 |
DOI:10.3760/cma.j.cn112271-20211102-00439 |
KeyWords:Primary liver cancer Preoperative radiotherapy Neoadjuvant therapy Immunotherapy |
FundProject:福建省自然科学基金引导性项目(2020Y0069);国家临床重点专科(放疗科)建设项目;福建省肿瘤放射与免疫治疗临床医学研究中心(2020Y2012) |
Author Name | Affiliation | E-mail | Liu Wenhui | Department of Radiation Oncology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China | | Zheng Xiaolian | Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China | | Hu Cairong | Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China | | Ji Hongbing | Department of Radiation Oncology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China | | Pan Jianji | Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China | | Chen Juhui | Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China | 13675043866@126.com |
|
Hits: 1806 |
Download times: 652 |
Abstract:: |
Liver cancer is one of the most common cancers in China. In recent years, liver cancer tends to be treated with comprehensive therapies, including surgery, ablation, interventional embolization, radiotherapy, chemotherapy, targeted therapy, immunotherapy, and liver transplantation. At present, the low surgical resectionrate is one of the main factors affecting the prognosis of liver cancer patients. Preoperative neoadjuvant therapy or conversion therapy for liver cancer can maximize the rate of surgical resection and improve the prognosis. With the rapid development of radiotherapy and immunotherapy in the comprehensive treatment of liver cancer, it has been gradually confirmed that the unique effects of preoperative radiotherapy and immune therapy for liver cancer can improve the prognosis of the patients. Therefore, this paper reviewed the research progress in the preoperative radiotherapy and immunotherapy for liver cancer by searching relevant literature and reports at home and abroad. |
HTML View Full Text View/Add Comment Download reader |
Close |
|
|
|